To The Moon

图片

You can snag these three healthcare stocks for less than a grand and set yourself up for future success!

1.Pfizer

Now is the perfect time to grab $Pfizer(PFE)$ stock. With 19 launches in 18 months and a string of acquisitions, including cancer expert $Seagen(SGEN)$ , Pfizer is poised to enter a new era of revenue growth.

The stock is trading at a forward P/E ratio of 12, which is a steal considering the company's long-term potential.

2.CRISPR Therapeutics

$CRISPR Therapeutics AG(CRSP)$ has bagged the world's first regulatory approval for a CRISPR-based gene editing product. The company's recently approved product, Casgevy, treats sickle cell disease and beta-thalassemia, which could be a hit with doctors and patients.

Plus, they have a solid pipeline of gene editing candidates in immuno-oncology, autoimmune diseases, and cardiovascular disease, predicting a “catalyst-rich” next 12 to 18 months.

So, to capitalize on this potential growth opportunity, now is the time to jump on this rising biopharma star.

3.Medtronic

$Medtronic PLC(MDT)$ , with its growing profits and dividend payments, is a long-term staple in any healthcare stock portfolio.

Over the past few years, Medtronic has streamlined its business, focusing on the fastest-growing opportunities and continuing to launch new products at a vibrant pace. In the past 12 months, they've received around 130 product approvals in key regions.

The company has also raised its full-year revenue and earnings per share guidance. In addition, Medtronic is putting a spotlight on the high-growth field of artificial intelligence (AI), with five approved AI products already in its arsenal.

The stock is trading at a forward P/E ratio of 16, making it a sweet deal.